Arrowstreet Capital, Limited Partnership Legend Biotech Corp Transaction History

Arrowstreet Capital, Limited Partnership

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $265,774 - $337,841	4,827 New	4,827 $271,000
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $5.44 Million - $7.77 Million	-140,184 Reduced 95.96%	5,903 $295,000
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $5.57 Million - $8.34 Million	146,087 New	146,087 $5.96 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $1.62 Million - $2.66 Million	-48,365 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$31.02 - $48.18 $1.5 Million - $2.33 Million	48,365 New	48,365 $1.76 Million
Q1 2021 May 14, 2021	SELL	$23.55 - $32.4 $194,970 - $268,239	-8,279 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$25.8 - $32.39 $213,598 - $268,156	8,279 New	8,279 $233,000

212

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.